NRT News Alert North European Oil Royality Trust (NRT) 12.68

New Post Public Reply Private Reply Replies (0) Message Board

Dec 25, 2014 at 5:48 PM

North European Oil Royality Trust (NRT) 12.68 $NRT

Novogen expects another AUD1.75m from private placement to US Institutions
M2 - Mon Dec 22, 6:08AM CST
Biotechnology company Novogen (ASX:NRT)(NASDAQ:NVGN) said on Friday that it expects to raise gross proceeds of about AUD1.75m in a second private placement.
NVGN: 2.40 (-0.09), NRT: 12.68 (-0.09)

39.0% Return Seen to Date on SmarTrend North European Oil Royalty Trust Call (NRT)
Comtex SmarTrend(R) - Fri Dec 19, 4:52PM CST
SmarTrend identified a Downtrend for North European Oil Royalty Trust (NYSE:NRT) on May 20th, 2014 at $22.94. In approximately 7 months, North European Oil Royalty Trust has returned 38.97% as of today's recent price of $14.00.
NRT: 12.68 (-0.09)

Novogen anticipates AUD4.1m from private placement
M2 - Thu Dec 18, 7:22AM CST
Biotechnology company Novogen (ASX:NRT)(NASDAQ:NVGN) said on Wednesday that it expects an aggregate gross proceeds of AUD4.1m from a private placement.
NVGN: 2.40 (-0.09), NRT: 12.68 (-0.09)

North European Oil Royalty Trust Down 46.6% Since SmarTrend Downtrend Call (NRT)
Comtex SmarTrend(R) - Fri Dec 12, 11:12AM CST
SmarTrend identified a Downtrend for North European Oil Royalty Trust (NYSE:NRT) on May 20th, 2014 at $22.94. In approximately 7 months, North European Oil Royalty Trust has returned 46.60% as of today's recent price of $12.25.
NRT: 12.68 (-0.09)

North European Oil Royalty Trust Has Returned 39.0% Since SmarTrend Recommendation (NRT)
Comtex SmarTrend(R) - Fri Dec 05, 9:49AM CST
SmarTrend identified a Downtrend for North European Oil Royalty Trust (NYSE:NRT) on May 20th, 2014 at $22.94. In approximately 7 months, North European Oil Royalty Trust has returned 38.97% as of today's recent price of $14.00.
NRT: 12.68 (-0.09)

North European Oil Royalty Trust Shares Down 32.4% Since SmarTrend's Sell Call (NRT)
Comtex SmarTrend(R) - Fri Nov 28, 9:25AM CST
SmarTrend identified a Downtrend for North European Oil Royalty Trust (NYSE:NRT) on May 20th, 2014 at $22.94. In approximately 6 months, North European Oil Royalty Trust has returned 32.43% as of today's recent price of $15.50.
NRT: 12.68 (-0.09)

Shares of NRT Down 28.5% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Wed Nov 19, 4:51PM CST
SmarTrend identified a Downtrend for North European Oil Royalty Trust (NYSE:NRT) on May 20th, 2014 at $22.94. In approximately 6 months, North European Oil Royalty Trust has returned 28.47% as of today's recent price of $16.41.
NRT: 12.68 (-0.09)

NYSE stocks posting largest volume increases
AP - Tue Nov 18, 5:03PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:
AGN: 210.12 (+0.95), CODI: 15.99 (-0.11), OME: 10.00 (+0.09), HAL: 39.70 (-0.18), NRT: 12.68 (-0.09), MC: 35.26 (+0.09), BLT: 17.52 (+0.17), DKL: 34.35 (+0.01), BHI: 56.34 (-0.10)

North European Oil Royalty Trust reports FQ4 results
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 11:55AM CST

NRT: 12.68 (-0.09)

North European Oil Royalty Trust Announces Net Income And Results For The Fourth Quarter Of Fiscal 2014
PR Newswire - Wed Nov 12, 11:29AM CST
North European Oil Royalty Trust (NYSE: NRT) reported the net income and results for the fourth quarter of fiscal 2014 which appear below compared with the fourth quarter of fiscal 2013.
NRT: 12.68 (-0.09)

24.3% Return Seen to Date on SmarTrend North European Oil Royalty Trust Call (NRT)
Comtex SmarTrend(R) - Wed Nov 12, 11:04AM CST
SmarTrend identified a Downtrend for North European Oil Royalty Trust (NYSE:NRT) on May 20th, 2014 at $22.94. In approximately 6 months, North European Oil Royalty Trust has returned 24.32% as of today's recent price of $17.36.
NRT: 12.68 (-0.09)

North European Oil Royalty Trust Has Returned 20.1% Since SmarTrend Recommendation (NRT)
Comtex SmarTrend(R) - Wed Nov 05, 9:39AM CST
SmarTrend identified a Downtrend for North European Oil Royalty Trust (NYSE:NRT) on May 20th, 2014 at $22.94. In approximately 6 months, North European Oil Royalty Trust has returned 20.05% as of today's recent price of $18.34.
NRT: 12.68 (-0.09)

North European Oil Royalty Trust declares $0.39 distribution
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 11:26AM CDT

NRT: 12.68 (-0.09)

North European Oil Royalty Trust Announces The Distribution For The Fourth Quarter Of Fiscal 2014
PR Newswire - Thu Oct 30, 11:11AM CDT
The Trustees of North European Oil Royalty Trust (NYSE: NRT) today announced a quarterly distribution of $0.39 per unit for the fourth quarter of fiscal 2014, payable on November 26, 2014 to holders of record on November 14, 2014. Natural gas sold during the third calendar quarter of 2014 is the primary source of royalty income on which the November distribution is based.
NRT: 12.68 (-0.09)

North European Oil Royalty Trust Shares Down 18.2% Since SmarTrend's Sell Call (NRT)
Comtex SmarTrend(R) - Wed Oct 29, 9:14AM CDT
SmarTrend identified a Downtrend for North European Oil Royalty Trust (NYSE:NRT) on May 20th, 2014 at $22.94. In approximately 5 months, North European Oil Royalty Trust has returned 18.22% as of today's recent price of $18.76.
NRT: 12.68 (-0.09)

Shares of NRT Down 14.8% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Tue Oct 21, 4:48PM CDT
SmarTrend identified a Downtrend for North European Oil Royalty Trust (NYSE:NRT) on May 20th, 2014 at $22.94. In approximately 5 months, North European Oil Royalty Trust has returned 14.81% as of today's recent price of $19.54.
NRT: 12.68 (-0.09)

Downtrend Call Working As North European Oil Royalty Trust Stock Falls 12.8% (NRT)
Comtex SmarTrend(R) - Tue Oct 07, 9:55AM CDT
SmarTrend identified a Downtrend for North European Oil Royalty Trust (NYSE:NRT) on May 20th, 2014 at $22.94. In approximately 5 months, North European Oil Royalty Trust has returned 12.82% as of today's recent price of $20.00.
NRT: 12.68 (-0.09)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

CVS Study: GLP-1 Drugs Effective But Costly

By Hannah Lewis Updated Nov 15, 2026 Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Uber Data Breach: Class Action Investigation Begins

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Championing Change: USTA Mid-Atlantic Gala's Impact

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Employment Law Suit Hits ABC: Alleged Wage Violations

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

JOYEE N01 Debuts Globally with First 2,000 Deliveries

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Viking Ventures: Impacts of VK2735 on Obesity Examined

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...